The latest data point for SMR's EPS Diluted in Q1'26 stands at -0.14 USD, reflecting a modest quarterly loss compared to the prior period's -0.8 USD in Q4'25, though it remains in negative territory indicative of ongoing profitability challenges. Over the period from Q2'23 to Q1'26, EPS Diluted has exhibited high volatility with persistent negative values, starting at -0.13 USD and worsening to a low of -1.85 USD in Q3'25 before a partial recovery to -0.14 USD; notable declines include a sharp drop to -0.77 USD in Q4'24 and -1.85 USD in Q3'25, while brief improvements occurred in Q3'24 (-0.18 USD) and Q1'25 (-0.11 USD). Year-over-year EPS Growth has been predominantly negative, with extreme downturns like -208% in Q4'24 and -928% in Q3'25, offset by occasional positive shifts such as 31% in Q3'24 and 58% in Q2'25, underscoring an unstable trend toward deeper losses amid fluctuating operational performance.